341 results on '"Chokshi, S"'
Search Results
52. P612 OSTEOPONTIN NEUTRALIZATION ABROGATES THE LIVER PROGENITOR CELL RESPONSE AND FIBROGENIC OUTCOMES IN MICE
53. P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTS
54. PS079 - Dynamin Related Protein-1 as a Novel Therapeutic Target for Alcoholic Liver Disease
55. FRI-230 - Osteopontin Promotes Cholangiocyte Chemokine Secretion and Macrophage Accumulation in Murine Liver Fibrosis
56. THU-206 - Pro-Fibrogenic Host Protein Osteopontin Participates in HBV Replication and HBSAG Secretion
57. PS075 - Dramatic Alterations of Anti-Bacterial Mait-Cell Network in Alcoholic Liver Disease
58. 547 DOWN-REGULATION OF TOLL-LIKE RECEPTOR-2 AND -4 IN CIRCULATING NEUTROPHILS IN RESPONSE TO SYSTEMIC OXIDATIVE STRESS MAY CONTRIBUTE TO INCREASED SUSCEPTIBILITY TO INFECTION IN ALCOHOLIC HEPATITIS
59. 541 SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS: A NOVEL ROLE FOR PD-1 AND GALECTIN-9?
60. 522 DIFFERENTIAL MITOCHONDRIAL DYNAMICS ARE OBSERVED IN ACUTE VERSUS CHRONIC ALCOHOL EXPOSURE IN AN IN VITRO MODEL OF LIVER TOXICITY
61. PWE-290 Active alcohol consumption induces functional immune paresis but paradoxically promotes endotoxin tolerance in those with advanced alcohol-related cirrhosis
62. PTU-040 Alcohol: always detrimental to the immune system? The role of active alcohol consumption on neutrophil function in alcohol-related cirrhosis
63. PTU-043 Development of a liver-specific, tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma
64. PMO-146 The soluble antagonistic form of IFN-inducible-protein-10 (IP-10) is a predictor of clinical outcome during acute hepatitis C infection
65. PTU-009 Alcohol-induced liver toxicity is associated with neutrophil dysfunction in a novel in-vitro model of acute liver injury
66. PMO-125 Neutrophil intracellular toll-like receptor (TLR) 9 expression serves as a biomarker that determines presence and severity of encephalopathy in acute liver failure and cirrhosis
67. PMO-117 Perturbation of the mitochondrial network architecture in an in vitro model of alcohol-induced liver toxicity
68. PMO-152 Characterising the immune status of HBV-specific CD4+ and CD8+ T-cells producing IL-17 in patients with chronic hepatitis B (CHB) virus infection
69. PWE-291 MAPK signalling regulates the development of a cholangiocellular phenotype from HCC in post-TACE liver transplants
70. 775 CHARACTERISING THE IMMUNE STATUS OF HBV-SPECIFIC CD4– AND CD8– T-CELLS PRODUCING IL-17 IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) VIRUS INFECTION
71. 283 MIXED-PHENOTYPE HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTS AFTER USE OF TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IS ASSOCIATED WITH ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) SIGNALLING PATHWAY
72. 808 THE SOLUBLE ANTAGONISTIC FORM OF IFN-INDUCIBLE-PROTEIN-10 (IP-10) IS A PREDICTOR OF CLINICAL OUTCOME DURING ACUTE HEPATITIS C INFECTION
73. 265 DEVELOPMENT OF A LIVER-SPECIFIC, TUMOUR-SELECTIVE RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR TO TARGET HEPATOCELLULAR CARCINOMA
74. 1366 PERTURBATION OF THE MITOCHONDRIAL NETWORK ARCHITECTURE IN AN IN VITRO MODEL OF ALCOHOL-INDUCED LIVER TOXICITY
75. 1361 ALCOHOL-INDUCED LIVER TOXICITY IS ASSOCIATED WITH NEUTROPHIL DYSFUNCTION IN A NOVEL IN-VITRO MODEL OF ACUTE LIVER INJURY
76. 245 NEUTROPHIL INTRACELLULAR TOLL-LIKE RECEPTOR (TLR) 9 EXPRESSION SERVES AS A BIOMARKER THAT DETERMINES PRESENCE AND SEVERITY OF ENCEPHALOPATHY IN ACUTE LIVER FAILURE AND CIRRHOSIS
77. 506 ALISPORIVIR-INDUCED INHIBITION OF CELLULAR CYCLOPHILINS DISRUPTS HEPATITIS B VIRUS (HBV) REPLICATION IN VITRO AND IS SYNERGISTIC IN COMBINATION WITH DIRECT ANTIVIRAL TARGETING HBV-DNA POLYMERASE
78. P5-13-24: A Predictive Model of Early Systemic Disease Relapse after Standard Adjuvant Therapy for Breast Cancer.
79. P43 Cellular protein cyclophilin A is involved in hepatitis B virus replication and its inhibition with DEB025 (alisporivir) or NIM811 demonstrates antiviral activity in vitro
80. Comparison of low-temperature-sensitive liposome encapsulated docetaxel and doxorubicin in a murine model of prostate cancer.
81. 1104 CHARACTERIZATION OF ANTIVIRAL ACTIVITIES OF CYCLOPHILIN INHIBITORS DEB025 (ALISPORIVIR) AND NIM811 ON HEPATITIS B VIRUS (HBV) REPLICATION AND HBSAG SECRETION IN VITRO
82. 611 HEPATITIS B VIRUS UPREGULATES HEPATOCYTE EXPRESSION OF PDL1 TO EVADE HEPATOXIC ADAPTIVE IMMUNE RESPONSES
83. 702 SPONTANEOUS RESOLUTION OF ACUTE HEPATITIS C VIRUS (HCV) INFECTION CORRELATES WITH THE RECONSTITUTION OF THE CIRCULATING CD56DIM NATURAL KILLER (NK)-CELL POOL
84. 714 COLLABORATIVE UK STUDY OF CHRONIC HEPATITIS B VIRUS INFECTION
85. 575 THE ROLE OF APOBEC AND INOS IN MEDIATING THE NON-CYTOLYTIC CONTROL OF HEPATITIS B VIRUS REPLICATION
86. 352 INTERFERON-γ INDUCIBLE PROTEIN-10 (IP-10) IS A PREDICTOR OF OUTCOME DURING THE ACUTE PHASE OF HCV INFECTION
87. 576 VALIDATION OF THE ENZYME-LINKED-IMMUNOSPOT (ELISPOT) ASSAY AS A STANDARDISED IMMUNOLOGICAL TEST FOR CLINICAL TRIALS
88. 889 CHRONIC HEPATITIS C (CHCV) IS ASSOCIATED WITH HYPEREXPRESSION OF PROGRAMMED DEATH (PD)-1 PATHWAY ON THE CELLULAR SUBSETS OF THE HOST ADAPTIVE/INNATE IMMUNE RESPONSE
89. 122 PD-1/PDL1 PATHWAY IS KEY IN DETERMINING THE BALANCE OF CURATIVE OR DESTRUCTIVE FUNCTION OF VIRUS-SPECIFIC CD8+ T-CELLS IN HBV INFECTION
90. 613 EFFECT OF CHRONIC HCV INFECTION ON HELPER T CELL SKEWING CAPACITY OF CIRCULATING PLASMACYTOID DENDRITIC CELLS. THE INFLUENCE OF ANTIVIRAL TREATMENT (RIBAVIRIN)
91. 571 NOVEL MECHANISM OF ACTION OF ANTI-HBS ANTIBODIES IN SUPRESSING HBSAG AND VIRUS RELEASE FROM HEPATOMA CELLS
92. 70 LONGITUDINAL ANALYSIS OF PD1 EXPRESSION: IMPACT OF HBEAG SEROCONVERSION DURING ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B
93. [448] CORRELATES OF INNATE AND ADAPTIVE IMMUNITY DURING ACUTE HCV INFECTION: IMPLICATIONS FOR CHRONIC VIRAL PERSISTENCE
94. [411] INTERFERON-GAMMA (IFN-y)-INDUCIBLE INTRA-CELLULAR INACTIVATION OF HEPATITIS B VIRUS (HBV): COMPARISON OF APOBEC3 AND NITRIC OXIDE PATHWAYS
95. [401] IMPACT OF MULTIPLE TREATMENT INTERRUPTIONS ON VIRUS-HOST INTERACTIONS IN HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)
96. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
97. Interferon treatment failure: The role of HCV-specific cellular and humoral immune responses for selection of HCV population.
98. Research 2.0: Research-supporting features of World Wide Web.
99. CD8+ T-lymphocyte control of hepatitis B virus replication: Direct comparison between cytolytic and non-cytolytic effects
100. Hepatitis B virus-specific T-cell reactivity during adefovir dipivoxil (ADV) treatment: a multicentre, controlled study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.